Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ultrase MT12 in the Control of Steatorrhea in Cystic Fibrosis (CF) and Pancreatic Insufficient (PI) Children Aged 2 to 6 Years Old

NCT00880100 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00880100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00880100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ultrase MT12 in the Control of Steatorrhea in Cystic Fibrosis (CF) and Pancreatic Insufficient (PI) Children Aged 2 to 6 Years Old
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2009
Completion date
November 30, 2009
Enrollment
49 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, pancreatic insufficiency